8-K Announcements
6Material company update
Apr 29, 2026·SEC
Material company update
Apr 20, 2026·SEC
Material company update
Apr 10, 2026·SEC
Humana Inc.(HUM)Earnings, Financials & Key Ratios
HUM•NYSE•Insurance & Managed Care
$246.33
$29.57B mkt cap·25.0× P/E·Price updated May 6, 2026
AboutHumana Inc., together with its subsidiaries, operates as a health and well-being company in the United States. It operates through three segments: Retail, Group and Specialty, and Healthcare Services. The company offers medical and supplemental benefit plans to individuals. It also has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits. In addition, the company provides commercial fully insured medical and specialty health insurance benefits comprising dental, vision, and other supplemental health benefits; and administrative services only products to individuals and employer groups, as well as military services, such as TRICARE T2017 East Region contract. Further, it offers pharmacy solutions, provider services, and home solutions services, such as home health and other services to its health plan members, as well as to third parties. As of December 31, 2021, the company had approximately 17 million members in medical benefit plans, as well as approximately 5 million members in specialty products. Humana Inc. was founded in 1961 and is headquartered in Louisville, Kentucky.Show more
- Revenue$129.66B+10.1%
- Combined Ratio98.88%+0.3%
- Net Income$1.19B-1.6%
- Return on Equity6.95%-5.7%
- Medical Cost Ratio85.46%
- Operating Margin1.12%-18.9%
- Net Margin0.92%-10.6%
- ROA2.5%-3.5%
- Equity / Assets36.38%+2.5%
- Book Value per Share146.80+7.9%
- Tangible BV/Share57.30+28.9%
- Debt/Equity0.73-2.2%
HUM Key Insights
Humana Inc. (HUM) fundamental analysis — strengths, weaknesses & financial health based on data analysis
✓Strengths
No significant strengths identified
✗Weaknesses
- ✗Profits declining 18.8% over 5 years
- ✗High loss ratio of 85.5%
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
HUM Price & Volume
Humana Inc. (HUM) stock price & volume — 10-year historical chart
Loading chart...
HUM Growth Metrics
Humana Inc. (HUM) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years9.1%
5 Years10.93%
3 Years11.75%
TTM14.08%
Profit CAGR
10 Years-0.71%
5 Years-18.81%
3 Years-24.91%
TTM-33.92%
EPS CAGR
10 Years1.55%
5 Years-17.22%
3 Years-23.62%
TTM-33.92%
Return on Capital
10 Years11.12%
5 Years8.12%
3 Years6.17%
Last Year3.95%
HUM Recent Earnings
Humana Inc. (HUM) EPS & revenue vs analyst estimates — last 4 quarters
●Beat EPS 11/12 qtrs (92%)●Beat Revenue 11/12 qtrs (92%)
Q2 2026Latest
Apr 29, 2026EPS
$10.31
Est $9.97
+3.4%
Revenue
$39.6B
Est $39.4B
+0.7%
Q1 2026
Feb 11, 2026EPS
$3.96
Est $4.00
+1.0%
Revenue
$32.5B
Est $32.0B
+1.5%
Q4 2025
Nov 5, 2025EPS
$3.24
Est $2.93
+10.6%
Revenue
$32.6B
Est $32.0B
+2.0%
Q3 2025
Jul 30, 2025EPS
$6.27
Est $5.92
+5.9%
Revenue
$32.4B
Est $31.9B
+1.6%
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | Apr 29, 2026 | $10.31vs $9.97+3.4% | $39.6Bvs $39.4B+0.7% |
| Q1 2026 | Feb 11, 2026 | $3.96vs $4.00+1.0% | $32.5Bvs $32.0B+1.5% |
| Q4 2025 | Nov 5, 2025 | $3.24vs $2.93+10.6% | $32.6Bvs $32.0B+2.0% |
| Q3 2025 | Jul 30, 2025 | $6.27vs $5.92+5.9% | $32.4Bvs $31.9B+1.6% |
Based on last 12 quarters of dataView full earnings history →
HUM Peer Comparison
Humana Inc. (HUM) competitors in National Multi-Line Health Insurers — business model, growth, and fundamentals comparison
| Company | Market Cap | Stock Price | P/E Ratio (TTM) | Revenue Growth 1Y | Net Margin | Return on Equity (ROE) | FCF Yield | Debt / Equity |
|---|---|---|---|---|---|---|---|---|
 UNH | 333.37B | 367.28 | 27.76 | 11.81% | 2.68% | 11.54% | 0.77 | |
 CVS | 111.32B | 86.86 | 62.49 | 7.85% | 0.72% | 3.86% | 1.24 | |
 ELV | 81.37B | 374.71 | 14.92 | 12.62% | 2.62% | 11.92% | 0.75 | |
 CNC | 27.31B | 55.32 | -4.06 | 19.44% | -3.25% | -28.6% | 0.94 | |
 MOH | 10.28B | 197.44 | 22.13 | 11.75% | 0.42% | 4.44% | 0.97 | |
 ALHC | 3.71B | 18.14 | -4902.70 | 46.06% | 0.47% | 11.5% | 1.89 | |
 OSCR | 5.14B | 19.84 | -11.74 | 27.5% | -0.3% | -3.26% | 0.44 | |
 CLOV | 1.37B | 2.68 | -15.76 | 40.34% | -2.58% | -17.08% |
Compare HUM vs Peers
Humana Inc. (HUM) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
HUM Income Statement
Humana Inc. (HUM) annual income statement — 10-year revenue, gross profit & net income history
10Y historyFree accessUpdated daily
| Line item | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 53.8B | 56.94B | 64.93B | 77.19B | 83.65B | 92.92B | 106.44B | 117.81B | 129.66B | 137.2B |
| Revenue Growth % | -1.11% | 5.84% | 14.03% | 18.88% | 8.37% | 11.09% | 14.55% | 10.68% | 10.06% | 14.08% |
| Medical Costs & Claims | 43.39B | 45.75B | 53.74B | 61.5B | 69.2B | 75.69B | 88.39B | 100.66B | 110.81B | 117.98B |
| Medical Cost Ratio % | 80.65% | 80.35% | 82.76% | 79.67% | 82.73% | 81.46% | 83.05% | 85.45% | 85.46% | 85.99% |
| Gross Profit | 7.08B▲ 0% | 11.19B▲ 58.0% | 11.19B▲ 0.0% | 15.69B▲ 40.2% | 14.45B▼ 7.9% | 17.23B▲ 19.3% | 18.05B▲ 4.7% | 17.15B▼ 5.0% | 18.85B▲ 9.9% | 19.22B▲ 0% |
| Gross Margin % | 13.17% | 19.65% | 17.24% | 20.33% | 17.27% | 18.54% | 16.95% | 14.55% | 14.54% | 14.01% |
| Gross Profit Growth % | -8.79% | 57.95% | 0.02% | 40.18% | -7.91% | 19.26% | 4.72% | -4.98% | 9.94% | - |
| Operating Expenses | 7.08B | 9.12B | 7.72B | 11.02B | 11.03B | 13.67B | 14.73B | 15.52B | 17.4B | 17.83B |
| OpEx / Revenue % | 13.17% | 16.01% | 11.89% | 14.27% | 13.19% | 14.71% | 13.84% | 13.17% | 13.42% | 13% |
| Depreciation & Amortization | 485M | 534M | 575M | 616M | 713M | 845M | 917M | 968M | 824M | 803M |
| Combined Ratio % | 93.82% | 96.36% | 94.66% | 93.94% | 95.91% | 96.16% | 96.88% | 98.62% | 98.88% | 98.99% |
| Operating Income | 3.33B▲ 0% | 2.07B▼ 37.6% | 3.47B▲ 67.3% | 4.67B▲ 34.7% | 3.42B▼ 26.9% | 3.56B▲ 4.2% | 3.32B▼ 6.8% | 1.63B▼ 51.0% | 1.45B▼ 10.7% | 1.38B▲ 0% |
| Operating Margin % | 6.18% | 3.64% | 5.34% | 6.06% | 4.09% | 3.84% | 3.12% | 1.38% | 1.12% | 1.01% |
| Operating Income Growth % | 91.04% | -37.64% | 67.31% | 34.7% | -26.85% | 4.24% | -6.85% | -50.99% | -10.69% | - |
| EBITDA | 3.81B | 2.61B | 4.04B | 5.29B | 4.13B | 4.41B | 4.24B | 2.6B | 2.28B | 2.19B |
| EBITDA Margin % | 7.08% | 4.58% | 6.23% | 6.85% | 4.94% | 4.74% | 3.98% | 2.2% | 1.76% | 1.59% |
| Interest Expense | 242M | 218M | 242M | 283M | 326M | 401M | 493M | 660M | 631M | 664M |
| Non-Operating Income | 694M | -218M | -242M | -283M | -326M | -401M | -493M | -660M | -631M | -664M |
| Pretax Income | 4.02B▲ 0% | 2.07B▼ 48.4% | 3.47B▲ 67.3% | 4.67B▲ 34.7% | 3.42B▼ 26.9% | 3.56B▲ 4.2% | 3.32B▼ 6.8% | 1.63B▼ 51.0% | 1.45B▼ 10.7% | 1.38B▲ 0% |
| Pretax Margin % | 7.47% | 3.64% | 5.34% | 6.06% | 4.09% | 3.84% | 3.12% | 1.38% | 1.12% | 1.01% |
| Income Tax | 1.57B | 391M | 763M | 1.31B | 485M | 762M | 836M | 413M | 250M | 239M |
| Effective Tax Rate % | 39.1% | 18.85% | 21.99% | 27.96% | 14.19% | 21.38% | 25.18% | 25.38% | 17.21% | 17.27% |
| Net Income | 2.45B▲ 0% | 1.68B▼ 31.3% | 2.71B▲ 60.8% | 3.37B▲ 24.4% | 2.93B▼ 12.9% | 2.81B▼ 4.3% | 2.49B▼ 11.3% | 1.21B▼ 51.5% | 1.19B▼ 1.6% | 1.13B▲ 0% |
| Net Margin % | 4.55% | 2.96% | 4.17% | 4.36% | 3.51% | 3.02% | 2.34% | 1.02% | 0.92% | 0.82% |
| Net Income Growth % | 298.7% | -31.25% | 60.84% | 24.38% | -12.89% | -4.33% | -11.3% | -51.51% | -1.57% | -33.92% |
| EPS (Diluted) | 16.81▲ 0% | 12.16▼ 27.7% | 20.10▲ 65.3% | 25.31▲ 25.9% | 22.67▼ 10.4% | 22.08▼ 2.6% | 20.00▼ 9.4% | 9.98▼ 50.1% | 9.84▼ 1.4% | 9.37▲ 0% |
| EPS Growth % | 313.02% | -27.66% | 65.3% | 25.92% | -10.43% | -2.6% | -9.42% | -50.1% | -1.4% | -33.92% |
| EPS (Basic) | 16.94 | 12.24 | 20.19 | 25.47 | 22.79 | 22.20 | 20.09 | 10.01 | 9.87 | - |
| Diluted Shares Outstanding | 145.58M | 138.4M | 134.73M | 133.01M | 129.4M | 127.09M | 124.44M | 120.87M | 120.83M | 120.65M |
HUM Balance Sheet
Humana Inc. (HUM) balance sheet — assets, liabilities & shareholders' equity
| Line item | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | 26.68B | 25.34B | 29.04B | 35.08B | 44.75B | 43.73B | 46.89B | 46.31B | 48.75B | 55.28B |
| Asset Growth % | 3.38% | -5.02% | 14.6% | 20.78% | 27.57% | -2.29% | 7.24% | -1.24% | 5.26% | 13.76% |
| Total Investment Assets | 12.3B | 11.48B | 12.44B | 14.94B | 14.11B | 15.01B | 17.75B | 19.33B | 16.83B | 4M |
| Long-Term Investments | 12.3B | 11.48B | 12.44B | 14.94B | 14.11B | 15.01B | 17.75B | 19.33B | 16.83B | 54.63B |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 17.01B |
| Total Current Assets | 4.9B | 3.36B | 5.11B | 5.81B | 5.21B | 6.74B | 6.73B | 4.92B | 7.47B | 27.18B |
| Cash & Equivalents | 4.04B | 2.34B | 4.05B | 4.67B | 3.39B | 5.06B | 4.69B | 2.22B | 4.2B | 4.95B |
| Receivables | 854M | 1.01B | 1.06B | 1.14B | 1.81B | 1.67B | 2.04B | 2.7B | 3.27B | 15.68B |
| Other Current Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill & Intangibles | 3.51B | 4.14B | 4.11B | 4.78B | 13.73B | 10.91B | 11.24B | 11.07B | 10.81B | 43.16B |
| Goodwill | 3.28B | 3.9B | 3.93B | 4.45B | 11.09B | 9.14B | 9.55B | 9.63B | 9.69B | 10.49B |
| Intangible Assets | 226M | 245M | 177M | 329M | 2.64B | 1.76B | 1.69B | 1.44B | 1.13B | 0 |
| PP&E (Net) | 1.58B | 1.74B | 2.37B | 2.81B | 3.75B | 3.74B | 3.54B | 2.98B | 2.72B | 2.17B |
| Other Assets | 3.85B | 4.38B | 4.79B | 6.44B | 7.37B | 6.49B | 7.58B | 7.74B | 10.83B | 14.18B |
| Total Liabilities | 16.84B | 15.18B | 17.01B | 21.35B | 28.64B | 28.36B | 30.57B | 29.87B | 31.01B | 36.63B |
| Total Debt | 4.92B | 6.07B | 6.11B | 7.14B | 13.22B | 11.75B | 12.27B | 12.26B | 12.94B | 13.99B |
| Net Debt | 878M | 3.73B | 2.06B | 2.47B | 9.83B | 6.69B | 7.58B | 10.04B | 8.74B | 9.04B |
| Long-Term Debt | 4.77B | 4.38B | 4.97B | 6.06B | 10.54B | 9.03B | 10.21B | 11.14B | 12.37B | 12.27B |
| Short-Term Debt | 150M | 1.69B | 815M | 729M | 2.14B | 2.26B | 1.61B | 724M | 150M | 1.72B |
| Total Current Liabilities | 4.37B | 6.53B | 6.8B | 9B | 10.49B | 11.63B | 11.95B | 11.26B | 10.31B | 21.51B |
| Accounts Payable | 3.84B | 4.55B | 5.74B | 7.95B | 8.1B | 9.08B | 10.07B | 10.27B | 9.81B | 19.22B |
| Deferred Revenue | 378M | 283M | 247M | 318M | 254M | 286M | 266M | 260M | 356M | 0 |
| Other Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 269M |
| Deferred Taxes | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 0 | 0 | 0 | 0 |
| Other Liabilities | 7.37B | 3.95B | 4.33B | 4.98B | 5.79B | 6.36B | 7.97B | 7.07B | 7.91B | 2.58B |
| Total Equity | 9.84B▲ 0% | 10.16B▲ 3.2% | 12.04B▲ 18.5% | 13.73B▲ 14.0% | 16.1B▲ 17.3% | 15.37B▼ 4.6% | 16.32B▲ 6.2% | 16.45B▲ 0.8% | 17.74B▲ 7.9% | 18.65B▲ 0% |
| Equity Growth % | -7.89% | 3.24% | 18.46% | 14.05% | 17.3% | -4.55% | 6.17% | 0.78% | 7.86% | 27.3% |
| Shareholders Equity | 9.84B | 10.16B | 12.04B | 13.73B | 16.08B | 15.31B | 16.26B | 16.38B | 17.66B | 18.58B |
| Minority Interest | 0 | 0 | 0 | 0 | 23M | 59M | 56M | 70M | 80M | 66M |
| Retained Earnings | 13.67B | 15.07B | 17.48B | 20.52B | 23.09B | 25.49B | 27.54B | 28.32B | 29.07B | 30.15B |
| Common Stock | 33M | 33M | 33M | 33M | 33M | 33M | 33M | 33M | 33M | 33M |
| Accumulated OCI | 19M | -159M | 156M | 391M | 42M | -1.3B | -999M | -1.07B | -633M | -731M |
| Return on Equity (ROE) | 23.85% | 16.83% | 24.39% | 26.14% | 19.66% | 17.83% | 15.71% | 7.37% | 6.95% | 6.17% |
| Return on Assets (ROA) | 9.33% | 6.47% | 9.95% | 10.5% | 7.35% | 6.34% | 5.49% | 2.59% | 2.5% | 2.21% |
| Equity / Assets | 36.88% | 40.09% | 41.45% | 39.14% | 35.99% | 35.15% | 34.8% | 35.51% | 36.38% | 33.73% |
| Debt / Equity | 0.50x | 0.60x | 0.51x | 0.52x | 0.82x | 0.76x | 0.75x | 0.75x | 0.73x | 0.73x |
| Book Value per Share | 67.60 | 73.42 | 89.34 | 103.21 | 124.45 | 120.93 | 131.13 | 136.06 | 146.80 | 154.54 |
| Tangible BV per Share | 43.51 | 43.49 | 58.87 | 67.30 | 18.33 | 35.12 | 40.78 | 44.44 | 57.30 | 67.61 |
HUM Cash Flow Statement
Humana Inc. (HUM) cash flow — operating, investing & free cash flow history
| Line item | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operations | 4.05B | 2.17B | 5.28B | 5.64B | 2.26B | 4.59B | 3.98B | 2.97B | 921M | 921M |
| Operating CF Growth % | 109.25% | -46.36% | 143.17% | 6.72% | -59.89% | 102.79% | -13.21% | -25.5% | -68.95% | 23.02% |
| Operating CF / Revenue % | 7.53% | 3.82% | 8.14% | 7.31% | 2.7% | 4.94% | 3.74% | 2.52% | 0.71% | 0.67% |
| Net Income | 2.45B | 1.68B | 2.71B | 3.37B | 2.93B | 2.8B | 2.49B | 1.21B | 1.2B | 1.13B |
| Depreciation & Amortization | 485M | 534M | 575M | 616M | 713M | 845M | 917M | 968M | 824M | 803M |
| Stock-Based Compensation | 157M | 137M | 163M | 181M | 180M | 216M | 175M | 207M | 241M | 243M |
| Deferred Taxes | 132M | 194M | 162M | 195M | 15M | -100M | -167M | -192M | 75M | 0 |
| Other Non-Cash Items | 141M | 792M | 14M | -863M | -1.02B | 290M | 486M | 615M | 375M | 453M |
| Working Capital Changes | 688M | -1.17B | 1.66B | 2.14B | -556M | 534M | 81M | 154M | -1.8B | -780M |
| Cash from Investing | -2.94B | -3.09B | -1.28B | -3.06B | -6.56B | -1.01B | -3.49B | -2.95B | 2.27B | -594M |
| Capital Expenditures | -526M | -612M | -736M | -964M | -1.34B | -1.14B | -1B | -575M | -546M | -572M |
| Acquisitions | -31M | -2.25B | 542M | -709M | -4.19B | 2.36B | -233M | -89M | -81M | -877M |
| Purchase of Investments | -6.26B | -4.69B | -6.36B | -9.13B | -7.2B | -6.05B | -7.55B | -8.19B | -6.44B | -8.51B |
| Sale/Maturity of Investments | 3.88B | 4.47B | 5.82B | 7.73B | 6.14B | 3.8B | 5.09B | 6.36B | 9.42B | 9.33B |
| Other Investing | 2M | -2.12B | -542M | 0 | 26M | 17M | 210M | -461M | -82M | 33M |
| Cash from Financing | -945M | -785M | -2.29B | -1.96B | 3.02B | -1.91B | -856M | -2.49B | -1.22B | -549M |
| Dividends Paid | -220M | -265M | -291M | -323M | -354M | -392M | -431M | -431M | -430M | -429M |
| Share Repurchases | -3.37B | -1.09B | -1.07B | -1.82B | -79M | -2.1B | -1.57B | -817M | -151M | -249M |
| Stock Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Debt Issuance (Net) | 1000K | 1000K | -1000K | 1000K | 1000K | -1000K | 1000K | 1000K | 1000K | -1000K |
| Other Financing | 1.89B | -595M | -511M | -890M | -310M | 1.97B | 725M | -1.46B | -1.17B | -595M |
| Net Change in Cash | 165M▲ 0% | -1.7B▼ 1129.7% | 1.71B▲ 200.7% | 619M▼ 63.8% | -1.28B▼ 306.6% | 1.67B▲ 230.3% | -367M▼ 122.0% | -2.47B▼ 573.8% | 1.98B▲ 180.0% | 701M▲ 0% |
| Exchange Rate Effect | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash at Beginning | 3.88B | 4.04B | 2.34B | 4.05B | 4.67B | 3.39B | 5.06B | 4.69B | 2.22B | 4.2B |
| Cash at End | 4.04B | 2.34B | 4.05B | 4.67B | 3.39B | 5.06B | 4.69B | 2.22B | 4.2B | 4.95B |
| Free Cash Flow | 3.52B▲ 0% | 1.56B▼ 55.7% | 4.55B▲ 191.4% | 4.67B▲ 2.8% | 920M▼ 80.3% | 3.45B▲ 275.0% | 2.98B▼ 13.7% | 2.39B▼ 19.7% | 375M▼ 84.3% | 1.27B▲ 0% |
| FCF Growth % | 150.18% | -55.72% | 191.35% | 2.79% | -80.32% | 275% | -13.71% | -19.68% | -84.32% | -46.58% |
| FCF Margin % | 6.55% | 2.74% | 7% | 6.06% | 1.1% | 3.71% | 2.8% | 2.03% | 0.29% | 0.93% |
| FCF per Share | 24.21 | 11.28 | 33.76 | 35.15 | 7.11 | 27.15 | 23.92 | 19.78 | 3.1 | 3.1 |
HUM Key Ratios
Humana Inc. (HUM) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Combined Ratio | 93.82% | 96.36% | 94.66% | 93.94% | 95.91% | 96.16% | 96.88% | 98.62% | 98.88% | 98.99% |
| Medical Cost Ratio | 80.65% | 80.35% | 82.76% | 79.67% | 82.73% | 81.46% | 83.05% | 85.45% | 85.46% | 85.99% |
| Return on Equity (ROE) | 23.85% | 16.83% | 24.39% | 26.14% | 19.66% | 17.83% | 15.71% | 7.37% | 6.95% | 6.17% |
| Return on Assets (ROA) | 9.33% | 6.47% | 9.95% | 10.5% | 7.35% | 6.34% | 5.49% | 2.59% | 2.5% | 2.21% |
| Equity / Assets | 36.88% | 40.09% | 41.45% | 39.14% | 35.99% | 35.15% | 34.8% | 35.51% | 36.38% | 33.73% |
| Book Value / Share | 67.6 | 73.42 | 89.34 | 103.21 | 124.45 | 120.93 | 131.13 | 136.06 | 146.8 | 154.54 |
| Debt / Equity | 0.50x | 0.60x | 0.51x | 0.52x | 0.82x | 0.76x | 0.75x | 0.75x | 0.73x | 0.73x |
| Revenue Growth | -1.11% | 5.84% | 14.03% | 18.88% | 8.37% | 11.09% | 14.55% | 10.68% | 10.06% | 14.08% |
HUM SEC Filings & Documents
Humana Inc. (HUM) SEC filings — annual & quarterly reports (10-K, 10-Q)
HUM Frequently Asked Questions
Humana Inc. (HUM) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
Humana Inc. (HUM) grew revenue by 10.1% over the past year. This is steady growth.
Yes, Humana Inc. (HUM) is profitable, generating $1.13B in net income for fiscal year 2025 (0.9% net margin).
Dividend & Returns
Yes, Humana Inc. (HUM) pays a dividend with a yield of 1.44%. This makes it attractive for income-focused investors.
Humana Inc. (HUM) has a return on equity (ROE) of 7.0%. This is below average, suggesting room for improvement.
Industry Metrics
Humana Inc. (HUM) has a combined ratio of 98.9%. A ratio below 100% indicates underwriting profitability.
Explore More HUM
Humana Inc. (HUM) financial analysis — history, returns, DCA and operating performance tools
Full HUM Stock Analysis
Analyst verdict, bull/bear case, risk factors and peer comparison
Total Return Calculator
Historical returns with dividends reinvested
DCA Calculator
Dollar cost averaging vs lump sum
Dividend History
Yield, growth, payout safety & DRIP
Earnings History
EPS trends, net income & profitability
Price History
Long-term charts & historical price data
Revenue History
Sales growth patterns & revenue breakdown
Financial Ratios
30 years of market, efficiency and balance-sheet ratios
Valuation
DCF intrinsic value, peer multiples & estimates